Polymarket may have dramatically widened the scope of its testing as the Commodity Futures Trading Commission (CFTC) finally published the self-certification filings that appeared to be holding up the ...

It also lowered expected exome and genome revenue growth to at least 20%, from 33–35%, while maintaining volume growth of at least 30%. ・Stueland added that the company remains confident in its ...

New Lab Volume Index, Highlighting More Trends and Expanded Functionality, Shows Testing Capacity Being Absorbed by Doubling of Demand for Women’s Health, Led by Prenatal Testing New Lab Volume Index, ...

SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a leading provider of innovative healthcare information technologies and services that deliver artificial intelligence (AI)-enabled operational efficiency, ...